Drug Trial Radar · NCT05155137
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Last checked: Nov 20, 2026Latest source record: Jan 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
8,518
Planned (sponsor's estimate)
Start
Dec 20, 2021
Primary completion
Dec 14, 2029
Study completion Dec 14, 2030
Sponsor
- Lead sponsor
- Hospital Moinhos de VentoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ministry of Health, Brazil; World Stroke Organization
- First posted
- Dec 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 50 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase III, prospective, placebo-controlled randomized clinical trial involving 8,518 subjects with low to moderate stroke risk, followed for 3 years in Brazil. Participants will be randomized to receive either the polypill (valsartan 80 mg, amlodipine 5 mg, and rosuvastatin 10 mg), with dose adjustment of amlodipine to 2.5 mg for patients experiencing adverse events, or a placebo, and to either use the Stroke Riskometer for lifestyle modification or receive usual care. The purpose of the study is to test whether the polypill, alone or in combination with lifestyle modification, will reduce the incidence of stroke and cognitive impairment in this population.
Conditions
- Stroke
- Cognitive Decline
Interventions
Drug Capsule (Valsartan + Amlodipine + Rosuvastatin)Drug
Polypill with 3 medications (Valsartan 80 mg + Amlodipine 5 mg + Rosuvastatin 10 mg)
Stroke RiskometerBehavioral
Participants will be randomized to use Stroke Riskometer App for lifestyle modifications
Primary outcomes
What the sponsor says the trial is designed to measure.
- StrokeTime frame: 3 years
- Cognitive declineTime frame: 3 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Unidade de Saúde Santa Cecília / Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.